Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.

PURPOSE We report clinical outcomes at 1 year or more after high-dose-rate (HDR) electronic brachytherapy (EBT) using surface applicators for the treatment of nonmelanoma skin cancer (NMSC). METHODS AND MATERIALS From July 2009 to April 2012, 122 patients with 171 NMSC lesions were treated with EBT to a dose of 40Gy in eight fractions, delivered twice weekly. At followup, patients were assessed for acute and late toxicities, cosmesis, and local control. RESULTS Treatment of 171 lesions was completed in 122 patients with a mean age 73 years. There have been no recurrences to date with a mean followup of 10 months (range, 1-28 months). Followup data at 1 year or more were available for 46 lesions in 42 patients. Hypopigmentation (all Grade 1) was present in 5 (10.9%) of 46 lesions at 1 year. Other late effects at 1 year included dry desquamation, alopecia, and rash dermatitis, which occurred in 1 (2.2%), 1 (2.2%), and 3 (6.5%) of 46 lesions, respectively. No Grade 3 or higher adverse events were observed at any time point. Cosmesis was evaluated at 1 year for 42 of 46 lesions and was excellent for 39 (92.9%) and good for 3 (7.1%) of the 42 evaluable lesions. CONCLUSIONS Treatment of NMSC with HDR EBT using surface applicators was effective with no recurrences, good to excellent cosmesis, and acceptable toxicities at 1 year or more after treatment. HDR EBT provides a convenient nonsurgical treatment option for NMSC patients.

[1]  J. Cook,et al.  A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. , 2003, Archives of dermatology.

[2]  R. Piccinno,et al.  Radiotherapy of skin carcinomas of the pinna: a study of 115 lesions in 108 patients , 2004, International journal of dermatology.

[3]  V. Moravan,et al.  Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. , 2004, International journal of radiation oncology, biology, physics.

[4]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[5]  S. Feldman,et al.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. , 2015, JAMA dermatology.

[6]  M. Lockett,et al.  Radiotherapy for epithelial skin cancer. , 2001, International journal of radiation oncology, biology, physics.

[7]  A. Bhatnagar,et al.  The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer , 2010, Radiation oncology.

[8]  Brett M. Coldiron,et al.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.

[9]  R. Tsang,et al.  Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. , 2000, International journal of radiation oncology, biology, physics.

[10]  W. John Boscardin,et al.  Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. , 2011, Archives of dermatology.

[11]  A. Dickler,et al.  Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer , 2010, Radiation oncology.

[12]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[13]  A. Martinez,et al.  Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. , 2000, International journal of radiation oncology, biology, physics.

[14]  Michael C Kirk,et al.  Dosimetric characteristics of the Leipzig surface applicators used in the high dose rate brachy radiotherapy. , 2004, Medical physics.

[15]  S. Pohlmann,et al.  [The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator)]. , 1999, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[16]  D. Wazer,et al.  Experience With an Electronic Brachytherapy Technique for Intracavitary Accelerated Partial Breast Irradiation , 2010, American journal of clinical oncology.

[17]  S. Chan,et al.  Single fraction radiotherapy for small superficial carcinoma of the skin. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  E. Huang,et al.  Predictive factors for skin telangiectasia following post-mastectomy electron beam irradiation. , 2002, The British journal of radiology.

[19]  J. L. Smith,et al.  Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006 , 2011 .

[20]  S. Kunze,et al.  Indikationen und ergebnisse der HDR-afterloading-therapie bei erkrankungen der haut und schleimhaut mit standardisierten oberflächenapplikatoren (Leipzig-Applikator) , 1999, Strahlentherapie und Onkologie.

[21]  Facundo Ballester,et al.  A dosimetric study of Leipzig applicators. , 2005, International journal of radiation oncology, biology, physics.

[22]  C. Perez,et al.  External irradiation of epithelial skin cancer. , 1990, International journal of radiation oncology, biology, physics.

[23]  Rakesh R. Patel,et al.  Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial , 2010, OncoTargets and therapy.